{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:32:56Z","timestamp":1762144376629},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T00:00:00Z","timestamp":1114473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00213-005-2253-z","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:54:16Z","timestamp":1114610056000},"page":"366-376","source":"Crossref","is-referenced-by-count":69,"title":["Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition"],"prefix":"10.1007","volume":"180","author":[{"given":"Catherine C.","family":"Tenn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,26]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073858403252674","volume":"9","author":"A Abi-Dargham","year":"2003","unstructured":"Abi-Dargham A, Moore H (2003) Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9:404\u2013416","journal-title":"Neuroscientist"},{"key":"2253_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0920-9964(94)90035-3","volume":"12","author":"K Akiyama","year":"1994","unstructured":"Akiyama K, Kanzaki A, Tsuchida K, Ujike H (1994) Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr Res 12:251\u2013257","journal-title":"Schizophr Res"},{"key":"2253_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00428187","volume":"85","author":"B Angrist","year":"1985","unstructured":"Angrist B, Peselow E, Rubinstein M, Wolkin A, Rotrosen J (1985) Amphetamine response and relapse risk after depot neuroleptic discontinuation. Psychopharmacology 85:277\u2013283","journal-title":"Psychopharmacology"},{"key":"2253_CR4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00005053-198810000-00004","volume":"176","author":"I Baruch","year":"1988","unstructured":"Baruch I, Hemsley DR, Gray JA (1988) Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 176:598\u2013606","journal-title":"J Nerv Ment Dis"},{"key":"2253_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","volume":"49","author":"DL Braff","year":"1992","unstructured":"Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206\u2013215","journal-title":"Arch Gen Psychiatry"},{"key":"2253_CR6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234\u2013258","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson\u2019s disease. Trends Neurosci 13:272\u2013276","journal-title":"Trends Neurosci"},{"key":"2253_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0006-3223(03)00292-0","volume":"54","author":"SA Castner","year":"2003","unstructured":"Castner SA, Goldman-Rakic PS (2003) Amphetamine sensitization of hallucinatory\u2013like behaviours is dependent on prefrontal cortex in nonhuman primates. Biol Psychiatry 54:105\u2013110","journal-title":"Biol Psychiatry"},{"key":"2253_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"JT Coyle","year":"1996","unstructured":"Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3:241\u2013253","journal-title":"Harv Rev Psychiatry"},{"key":"2253_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s002130050513","volume":"135","author":"JP Druhan","year":"1998","unstructured":"Druhan JP, Geyer MA, Valentino RJ (1998) Lack of sensitization to the effects of d-amphetamine and apormorphine on sensorimotor gating in rats. Psychopharmacology 135:296\u2013304","journal-title":"Psychopharmacology"},{"key":"2253_CR11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s002130050170","volume":"129","author":"BA Ellenbroek","year":"1997","unstructured":"Ellenbroek BA, Knobbout DA, Cools AR (1997) The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology (Berl) 129:112\u2013120","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(01)00067-7","volume":"26","author":"M Escobar","year":"2002","unstructured":"Escobar M, Oberling P, Miller RR (2002) Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neurosci Biobehav Rev 26:203\u2013216","journal-title":"Neurosci Biobehav Rev"},{"key":"2253_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(85)90137-6","volume":"23","author":"BD Greenberg","year":"1985","unstructured":"Greenberg BD, Segal DS (1985) Acute and chronic behavioural interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors. Pharmacol Biochem Behav 23:99\u2013105","journal-title":"Pharmacol Biochem Behav"},{"key":"2253_CR14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"2253_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"2253_CR16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1523\/JNEUROSCI.17-05-01769.1997","volume":"17","author":"JD Jentsch","year":"1997","unstructured":"Jentsch JD, Elsworth JD, Redmond DE Jr, Roth RH (1997) Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J Neurosci 17:1769\u20131775","journal-title":"J Neurosci"},{"key":"2253_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0893-133X(98)00004-9","volume":"19","author":"JD Jentsch","year":"1998","unstructured":"Jentsch JD, Taylor JR, Roth RH (1998a) Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 19:105\u2013113","journal-title":"Neuropsychopharmacology"},{"key":"2253_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002130050649","volume":"138","author":"JD Jentsch","year":"1998","unstructured":"Jentsch JD, Tran A, Taylor JR, Roth RH (1998b) Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioural and neurochemical evidence. Psychopharmacology (Berl) 138:89\u201395","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<709::AID-JNR10>3.0.CO;2-U","volume":"52","author":"KM Johnson","year":"1998","unstructured":"Johnson KM, Phillips M, Wang C, Kevetter GA (1998) Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52:709\u2013722","journal-title":"J Neurosci Res"},{"key":"2253_CR20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0028-3908(85)90032-2","volume":"24","author":"MG Kolta","year":"1985","unstructured":"Kolta MG, Shreve P, De Souza V, Uretsky NJ (1985) Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24:823\u2013829","journal-title":"Neuropharmacology"},{"key":"2253_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","volume":"6","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6:869\u2013872","journal-title":"NeuroReport"},{"key":"2253_CR22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0165-0173(99)00054-5","volume":"31","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000) The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 31:371\u2013384","journal-title":"Brain Res Rev"},{"key":"2253_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","volume":"1003","author":"M Laruelle","year":"2003","unstructured":"Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine and schizophrenia. Ann N Y Acad Sci 1003:138\u2013158","journal-title":"Ann N Y Acad Sci"},{"key":"2253_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(97)00045-6","volume":"17","author":"JA Lieberman","year":"1997","unstructured":"Lieberman JA, Sheitman BB, Kinon BJ (1997) Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17:205\u2013229","journal-title":"Neuropsychopharmacology"},{"key":"2253_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-4328(97)02307-3","volume":"88","author":"RE Lubow","year":"1997","unstructured":"Lubow RE (1997) Latent inhibition as a measure of learned inattention: some problems and solutions. Behav Brain Res 88:75\u201383","journal-title":"Behav Brain Res"},{"key":"2253_CR26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0893-133X(98)00137-7","volume":"21","author":"ZA Martinez","year":"1999","unstructured":"Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR (1999) Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology 21:28\u201339","journal-title":"Neuropsychopharmacology"},{"key":"2253_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s002130100759","volume":"156","author":"CA Murphy","year":"2001","unstructured":"Murphy CA, Di Iorio L, Feldon J (2001a) Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response. Psychopharmacology (Berl) 156:155\u2013164","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1037\/0735-7044.115.6.1247","volume":"115","author":"CA Murphy","year":"2001","unstructured":"Murphy CA, Fend M, Russig H, Feldon J (2001b) Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 115:1247\u20131256","journal-title":"Behav Neurosci"},{"key":"2253_CR29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0028-3908(78)90045-X","volume":"17","author":"LR Nelson","year":"1978","unstructured":"Nelson LR, Ellison G (1978) Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 17:1081\u20131084","journal-title":"Neuropharmacology"},{"key":"2253_CR30","first-page":"975","volume":"49","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 49:975\u2013982","journal-title":"Arch Gen Psychiatry"},{"key":"2253_CR31","first-page":"905","volume":"296","author":"M Phillips","year":"2001","unstructured":"Phillips M, Wang C, Johnson KM (2001) Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration. J Pharmacol Exp Ther 296:905\u2013913","journal-title":"J Pharmacol Exp Ther"},{"key":"2253_CR32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0024-3205(80)90085-5","volume":"26","author":"RM Post","year":"1980","unstructured":"Post RM (1980) Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci 26:1275\u20131282","journal-title":"Life Sci"},{"key":"2253_CR33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF00431451","volume":"84","author":"TE Robinson","year":"1984","unstructured":"Robinson TE (1984) Behavioural sensitization: characterization of enduring changes in rotational behaviour produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology (Berl) 84:466\u2013475","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"396","author":"TE Robinson","year":"1986","unstructured":"Robinson TE, Becker JB (1986) Enduring changes in brain and behaviour produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157\u2013198","journal-title":"Brain Res"},{"key":"2253_CR35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0893-133X(01)00422-5","volume":"26","author":"H Russig","year":"2002","unstructured":"Russig H, Murphy CA, Feldon J (2002) Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal. Neuropsychopharmacology 26:765\u2013777","journal-title":"Neuropsychopharmacology"},{"key":"2253_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/schbul\/18.1.115","volume":"18","author":"M Sato","year":"1992","unstructured":"Sato M, Numachi Y, Hamamura T (1992) Relapse of paranoid psychotic state in methamphetamine model in schizophrenia. Schizophr Bull 18:115\u2013122","journal-title":"Schizophr Bull"},{"key":"2253_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0892-0362(92)90023-4","volume":"14","author":"FM Scalzo","year":"1992","unstructured":"Scalzo FM, Holson RR (1992) The ontogeny of behavioural sensitization to phencyclidine. Neurotoxicol Teratol 14:7\u201314","journal-title":"Neurotoxicol Teratol"},{"key":"2253_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0166-4328(98)00027-8","volume":"97","author":"U Schroeder","year":"1998","unstructured":"Schroeder U, Schroeder H, Darius J, Grecksch G, Sabel BA (1998) Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behav Brain Res 97:59\u201368","journal-title":"Behav Brain Res"},{"key":"2253_CR39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002130100776","volume":"156","author":"B Schulz","year":"2001","unstructured":"Schulz B, Fendt M, Pedersen V, Koch M (2001) Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine. Psychopharmacology (Berl) 156:177\u2013181","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR40","first-page":"743","volume":"17","author":"PR Solomon","year":"1982","unstructured":"Solomon PR, Staton DM (1982) Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat\u2019s ability to ignore an irrelevant stimulus. Biol Psychiatry 17:743\u2013756","journal-title":"Biol Psychiatry"},{"key":"2253_CR41","first-page":"519","volume":"16","author":"PR Solomon","year":"1981","unstructured":"Solomon PR, Crider A, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519\u2013537","journal-title":"Biol Psychiatry"},{"key":"2253_CR42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145703003675","volume":"6","author":"M Srisurapanont","year":"2003","unstructured":"Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M (2003) Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 6:347\u2013352","journal-title":"Int J Neuropsychopharmacol"},{"key":"2253_CR43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0920-9964(03)00009-4","volume":"64","author":"CC Tenn","year":"2003","unstructured":"Tenn CC, Fletcher PJ, Kapur S (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64:103\u2013114","journal-title":"Schizophr Res"},{"key":"2253_CR44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","volume":"42","author":"G Tsai","year":"2002","unstructured":"Tsai G, Coyle JT (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42:165\u2013179","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2253_CR45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0006-8993(00)03056-0","volume":"888","author":"SM Turgeon","year":"2001","unstructured":"Turgeon SM, Case LC (2001) The effects of phencyclidine pre-treatment on amphetamine-induced behaviour and c-Fos expression in the rat. Brain Res 888:302\u2013305","journal-title":"Brain Res"},{"key":"2253_CR46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11920-002-0024-7","volume":"4","author":"H Ujike","year":"2002","unstructured":"Ujike H (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4:177\u2013184","journal-title":"Curr Psychiatry Rep"},{"key":"2253_CR47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF02244998","volume":"114","author":"EC Warburton","year":"1994","unstructured":"Warburton EC, Joseph MH, Feldon J, Weiner I, Gray JA (1994) Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl) 114:657\u2013664","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","volume":"169","author":"I Weiner","year":"2003","unstructured":"Weiner I (2003) The \u201ctwo-headed\u201d latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) 169:257\u2013297","journal-title":"Psychopharmacology (Berl)"},{"key":"2253_CR49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0091-3057(92)90008-4","volume":"42","author":"I Weiner","year":"1992","unstructured":"Weiner I, Feldon J (1992) Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia. Pharmacol Biochem Behav 42:625\u2013631","journal-title":"Pharmacol Biochem Behav"},{"key":"2253_CR50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0091-3057(88)90113-X","volume":"30","author":"I Weiner","year":"1988","unstructured":"Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871\u2013878","journal-title":"Pharmacol Biochem Behav"},{"key":"2253_CR51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-3057(94)90165-1","volume":"47","author":"X Xu","year":"1994","unstructured":"Xu X, Domino EF (1994) Phencyclidine-induced behavioural sensitization. Pharmacol Biochem Behav 47:603\u2013608","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-2253-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2253-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:17Z","timestamp":1558629077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-2253-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,26]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-2253-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,26]]}}}